Cite
HARVARD Citation
Patel, C. et al. (2020). Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors. Clinical pharmacology in drug development. 9 (7), pp. 876-888. [Online].